PD04.07. Efficacy of Neoadjuvant CROSS and TPF for Esophageal Squamous Cell Carcinoma - a Propensity Score Matched Analysis
Esophageal Cancer: Oncology/Radiation Therapy Neoadjuvant therapy before resection has been shown to improve esophageal cancer-related survival and outcomes, but few studies have compared the outcomes from the two most widely used neoadjuvant protocols – the Taxotere, Platinol/Carbolatin, 5-fluorouracil (T...